Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |